JP2004531241A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004531241A5 JP2004531241A5 JP2002571545A JP2002571545A JP2004531241A5 JP 2004531241 A5 JP2004531241 A5 JP 2004531241A5 JP 2002571545 A JP2002571545 A JP 2002571545A JP 2002571545 A JP2002571545 A JP 2002571545A JP 2004531241 A5 JP2004531241 A5 JP 2004531241A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- nucleotide
- seq
- polypeptide
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002773 nucleotide Substances 0.000 claims 45
- 125000003729 nucleotide group Chemical group 0.000 claims 45
- 108020004707 nucleic acids Proteins 0.000 claims 32
- 102000039446 nucleic acids Human genes 0.000 claims 32
- 150000007523 nucleic acids Chemical class 0.000 claims 32
- 229920001184 polypeptide Polymers 0.000 claims 23
- 108090000765 processed proteins & peptides Proteins 0.000 claims 23
- 102000004196 processed proteins & peptides Human genes 0.000 claims 23
- 108020004635 Complementary DNA Proteins 0.000 claims 14
- 239000000523 sample Substances 0.000 claims 12
- 102100037129 ATP-binding cassette sub-family C member 11 Human genes 0.000 claims 8
- 101001029057 Homo sapiens ATP-binding cassette sub-family C member 11 Proteins 0.000 claims 8
- 125000003275 alpha amino acid group Chemical group 0.000 claims 8
- 238000000034 method Methods 0.000 claims 7
- 239000000556 agonist Substances 0.000 claims 6
- 239000005557 antagonist Substances 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- 206010008754 Choreoathetosis Diseases 0.000 claims 5
- 150000001450 anions Chemical class 0.000 claims 5
- 230000001314 paroxysmal effect Effects 0.000 claims 5
- 230000002265 prevention Effects 0.000 claims 5
- 239000003153 chemical reaction reagent Substances 0.000 claims 4
- 239000003550 marker Substances 0.000 claims 4
- 238000012216 screening Methods 0.000 claims 4
- 239000000758 substrate Substances 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 101150110927 ABCC11 gene Proteins 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 230000003321 amplification Effects 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 238000009396 hybridization Methods 0.000 claims 2
- 239000012528 membrane Substances 0.000 claims 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims 2
- 238000009007 Diagnostic Kit Methods 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 238000002372 labelling Methods 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27275701P | 2001-03-05 | 2001-03-05 | |
| PCT/EP2002/003241 WO2002072632A2 (en) | 2001-03-05 | 2002-03-05 | Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004531241A JP2004531241A (ja) | 2004-10-14 |
| JP2004531241A5 true JP2004531241A5 (enExample) | 2005-12-22 |
Family
ID=23041140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002571545A Pending JP2004531241A (ja) | 2001-03-05 | 2002-03-05 | ヒトａｂｃｃ１１遺伝子の核酸、このような核酸を含むベクター、およびこれらの使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US6893841B2 (enExample) |
| EP (1) | EP1385884A2 (enExample) |
| JP (1) | JP2004531241A (enExample) |
| CA (1) | CA2439702A1 (enExample) |
| WO (1) | WO2002072632A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1370585A2 (en) * | 2001-03-05 | 2003-12-17 | Aventis Pharma S.A. | Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof |
| US7049120B2 (en) * | 2001-03-09 | 2006-05-23 | Bayer Healthcare Ag | Regulation of human mrp5-like protein |
| US20080025981A1 (en) * | 2002-03-04 | 2008-01-31 | Young Paul E | Cancer-linked genes as targets for chemotherapy |
| AU2003213672A1 (en) * | 2002-03-04 | 2003-09-22 | Avalon Pharmaceuticals | Cancer-linked gene as target for chemotherapy |
| US20040049399A1 (en) * | 2002-09-10 | 2004-03-11 | Elisabeth Familian | Method and system for online donation and sending customized card |
| CN102016038A (zh) * | 2005-06-17 | 2011-04-13 | 国立大学法人长崎大学 | 耳垢型或狐臭症的评价方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7268222B1 (en) * | 1999-11-02 | 2007-09-11 | Lexicon Pharmaceuticals, Inc. | Polynucleotides encoding human transporter proteins |
| AU2001285145A1 (en) * | 2000-08-21 | 2002-03-04 | Millennium Pharmaceuticals, Inc. | Human abc transporter family member and uses thereof |
| CA2425569A1 (en) * | 2000-10-13 | 2002-04-18 | Eos Biotechnology, Inc. | Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| EP1370585A2 (en) * | 2001-03-05 | 2003-12-17 | Aventis Pharma S.A. | Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof |
-
2002
- 2002-03-05 WO PCT/EP2002/003241 patent/WO2002072632A2/en not_active Ceased
- 2002-03-05 EP EP02732521A patent/EP1385884A2/en not_active Ceased
- 2002-03-05 US US10/087,782 patent/US6893841B2/en not_active Expired - Lifetime
- 2002-03-05 CA CA002439702A patent/CA2439702A1/en not_active Abandoned
- 2002-03-05 JP JP2002571545A patent/JP2004531241A/ja active Pending
-
2005
- 2005-01-12 US US11/034,277 patent/US20050158784A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2456889T3 (en) | Markers of endometrial cancer | |
| US9115405B2 (en) | Alternative splicing variant of OATP1B3 mRNA | |
| EP3054299B1 (en) | Biomarkers for the early detection of breast cancer | |
| JP4229973B2 (ja) | 男性不妊関連遺伝子Ｓｃｏｔ−ｔ変異と男性不妊の診断方法 | |
| US20070178458A1 (en) | Methods of diagnosis and prognosis of ovarian cancer II | |
| CA2467629A1 (en) | Methods for evaluating drug-resistance gene expression in the cancer patient | |
| JP2008118915A (ja) | 胃癌高発現遺伝子特定による胃癌診断および創薬への利用 | |
| JP2008509673A5 (enExample) | ||
| CA2362527A1 (en) | A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer | |
| CN107075584A (zh) | Bcr‑abl抑制剂抗性相关突变的检测方法及使用该检测方法用于预测bcr‑abl抑制剂抗性的数据获得方法 | |
| WO2003073911A2 (en) | Method and composition for detection and treatment of breast cancer | |
| JP7150018B2 (ja) | 新規なｃｉｐ２ａバリアント及びその使用 | |
| US6682888B1 (en) | Genes expressed in alzheimer's disease | |
| KR20200102746A (ko) | 췌장암 진단용 조성물 | |
| KR20170124683A (ko) | 담도암 진단용 신규 바이오마커로서의 융합 유전자 및 융합 단백질 | |
| JP2007275054A (ja) | 胃癌腫のリンパ節転移の検出 | |
| JP2004537983A5 (enExample) | ||
| WO2003097872A2 (en) | G - protein coupled receptor marker molecules associated with colorectal lesions | |
| JP2009523004A5 (enExample) | ||
| CN102618545B (zh) | 与人癌细胞的永生化相关的基因及其应用 | |
| JP2005504830A5 (enExample) | ||
| CN104450887B (zh) | 用于检测子宫内膜癌的dna探针、基因芯片及其应用 | |
| JP2005253434A (ja) | ２型糖尿病の診断方法 | |
| Pascolo et al. | Detection of MRP1 mRNA in human tumors and tumor cell lines by in situ RT-PCR | |
| CN106868197B (zh) | 基因标志物在多发性骨髓瘤中的应用 |